Vascular update: Morphogenesis, tumors, malformations, and molecular dimensions

American Journal of Medical Genetics, Part A

Volumn 140, Issue 19, 2006, Pages 2013-2038

  Cohen Jr , M Michael ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Angiogenesis; GLUT1; Infantile hemangioma; Kaposi form hemangioendothelioma; Kasabach Merritt phenomenon; Lymphatic malformation; Noninvoluting congenital hemangioma (NICH); Rapidly involuting congenital hemangioma (RICH); Tufted angioma; Vasculogenesis

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; AE 941; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOPOIETIN; BEVACIZUMAB; CELECOXIB; CETUXIMAB; CILENGITIDE; ENDOSTATIN; ENZASTAURIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FAT; FIBROBLAST GROWTH FACTOR; GEFITINIB; INTEGRIN; METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE C; REBIMASTAT; SUNITINIB; THALIDOMIDE; TIE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VATALANIB; VEGF TRAP;

ANGIOGENESIS; ANGIOOSTEOHYPERTROPHY SYNDROME; BLOOD VESSEL; CLINICAL TRIAL; CONGENITAL BLOOD VESSEL MALFORMATION; DRUG ACTIVITY; HEMANGIOMA; HUMAN; INFANT DISEASE; KASABACH MERRITT SYNDROME; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NERVE; PRIORITY JOURNAL; REVIEW; STURGE WEBER SYNDROME; VASCULAR DISEASE; VASCULAR TUMOR;

EID: 33749491894     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31333     Document Type: Review

References (152)

1. Aelvoet AE, Jorens PG, Boelen LM. 1992. Genetic aspects of the Klippel-Trenaunay syndrome. Br J Dermatol 126:603-607.
2. Akimoto T, Hammerman MR. 2003. Fibroblast growth factor 2 promotes microvessel formation from mouse embryonic aorta. Am J Physiol Cell Physiol 284:C371-C377.
3. Alan R. 2005. Anti-angiogenesis: A new theory of cancer treatment. Health Information: Brigham and Women's Hospital, pp. 1-4.
4. Alitalo K, Tammela T, Petrova TV. 2005. Lymphangiogenesis in development and human disease. Nature 438:946-953.
5. Arrighi F. 1960. Hamartose ecto-mesodérmique: Un cas de fusion de maladie de Recklinghausen (avec éléphantiasis neuromateux de Virchow) et de maladie de Klippel-Trénaunay-Parkes Weber. Bull Soç Fr Dermatol Syphiligr 67:564.
6. Barker KT, Foulkes WD, Schwartz CE, Labadie C, Monsell F, Houlton RS, Harper J. 2006. Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes? J Med Genet: Online Jan 27.
7. Baskerville PA, Ackroyd JS, Browse NL. 1985. The etiology of the Klippel-Trénaunay syndrome. Ann Surg 202:624-627.
8. Bennett BD, Wang Z, Kuang W-J, Wang A, Groopman JE, Goeddel DV, Scadden DT. 1994. Cloning and characterization of HTK, a novel transmembrane tyrosine kinase of the EPH subfamily. J Biol Chem 269:14211-14218.
9. Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, Burrows PE, Perez-Atayde AR, Kozakewich HPW. 2003. Rapidly involuting congenital hemangioma: Clinical and histopathologic features. Pediatr Dev Pathol 6:495-510.
10. Bonaldo MF, Yu MT, Jelenc P, Brown S, Su L, Lawton L, Deaven L, Efstratiadis A, Warburton D, Soares MB. 1994. Selection of cDNAs using chromosome-specific genomic clones: Application to human chromosome 13. Hum Mol Genet 3:1663-1673.
11. Bonse G. 1951. Röntgenbefunde bei einer Phakomatose (Sturge-Weber kombiniert mit Klippel-Trénaunay). Fortschr Roentgenstr 74:727-729.
12. Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, Warman ML. 1994. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 3:1583-1587.
13. Boon LM, Brouillard P, Irrthum A, Karttunen L, Warman ML, Rudolph R, Mulliken JB, Olsen BR, Vikkula M. 1999. Agene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet 65:125-133.
14. th Annual Meeting, Toronto, Abstract 2413/F3.
15. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BJ, Bischoff J. 2001. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745-752.
16. Burns AJ, Kaplan LC, Mulliken JB. 1991. Is there an association between hemangioma and syndromes with dysmorphic features? Pediatrics 88:1257-1267.
17. Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA. 1999. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8:1279-1289.
18. Carcao M, Blaser SI, Grant RM, Weksberg R, Siegel-Bartelt J. 1998. Brief clinical report. MRI findings in macrocephaly-cutis marmorata telangiectatica congenita. Am J Med Genet 76:165-167.
19. Carmeliet P. 2005. Angiogenesis in life, disease and medicine. Nature 438:932-936.
20. Ceballos-Quintal JM, Pinto-Escalante D, Castillo-Zapata I. 1996. A new case of Klippel-Trenaunay-Weber (KTW) syndrome: Evidence of autosomal dominant inheritance. Am J Med Genet 63:426-427.
21. Cheng N-C, Lai D-M, Hsie M-H, Liao S-L, Chen Y-B Tang. 2006. Intraosseous hemangiomas of the facial bones. Plast Reconstr Surg 117:2366-2372.
22. Cheung DSM, Warman ML, Mulliken JB. 1997. Hemangioma in twins. Ann Plast Surg 38:269-274.
23. Clayton-Smith J, Kerr B, Brunner H, Tranebjaerg L, Magee A, Hennekam RCM, Mueller RF, Brueton L, Super M, Steen-Johnsen J, Donnai D. 1997. Macrocephaly with cutis marmorata, haemangioma, and syndactyly - a distinctive overgrowth syndrome. Clin Dysmorphol 6:291-302.
24. Cohen MM Jr. 1998. Some neoplasms and some hamartomatous syndrome: genetic considerations. Int J Oral Maxillofac Surg 27:363-369.
25. Cohen MM Jr. 2000. Klippel-Trenaunay syndrome: A critical analysis. Am J Med Genet 93:171-175.
26. Cohen MM Jr. 2002. Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations. Am J Med Genet 108:265-274.
27. Cohen MM Jr. 2003. Editorial comment: endothelium is essential for development of the liver and pancreas. Am J Med Genet Part A 122A:342.
28. Cohen MM Jr. 2005. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatric Dev Pathol 8:287-304.
29. Cohen MM Jr, Neri G, Weksberg R. 2002. Overgrowth Syndromes. New York: Oxford University Press.
30. Coultas L, Chawengsaksophak K, Rossant J. 2005. Endothelial cells and VEGF in vascular development. Nature 438:937-945.
31. Craven N, Wright AL. 1995. Familial Klippel-Trenaunay syndrome. A case report. Clin Exp Dermatol 20:76-79.
32. Dallabrida SM, Zurakowski D, Shih S-C, Smith LE, Folkman J, Moulton KS, Rupnick MA. 2003. Adipose tissue growth and regression are regulated by angiopoietin-1. Biochem Biophys Res Commun 311:563-571.
33. Deckers MM, Smits P, Karperien M, Ni J, Tylzanowski P, Feng P, Parmele D, Zhang J, Bouffard E, Gentz R. 2001. Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro. Bone 28:14-20.
34. Eerola I, Plate KH, Spiegel R, Boon LM, Mulliken JB, Vikkula M. 2000. KRIT1 is mutated in hyperkeratotic cutaneous capillary-venous malformation associated with cerebral capillary malformation. Hum Mol Genet 9:1351-1355.
35. Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M. 2003. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73:1240-1249.
36. Eltorky M, Chesney TM, Sebes J, Hall JC. 1994. Spindle cell hemangioendothelioma. J Dermatol Surg Oncol 20:196-202.
37. Enjolras O, Mulliken JB. 1998. Vascular tumors and vascular malformations. Adv Dermatol 13:375-422.
38. Enjolras O, Wassef M, Mazoyer E, Frieden IJ, Rieu PN, Drouet L, Taïeb A, Stalder J-F, Escande J-P. 1997. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 130:631-640.
39. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, Glover TW. 2000. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67:1382-1388.
40. Ferrara N, Alitalo K. 1999. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med 5:1159-1164.
41. Ferrara N, Kerbel RS. 2005. Angiogenesis as a therapeutic target. Nature 438:967-974.
42. Fishman S. 2005. Hepatic hemangiomas. In Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol 22:388.
43. Fletcher CDM, Beham A, Schmid C. 1991. Spindle-cell hemangioendothelioma: A clinicopathological and immunohistochemical study indicative of a nonneoplastic lesion. Histopathology 18:291-301.
44. Folkman J. 1971. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186.
45. Folkman J. 1972. Anti-angiogenesis: New concept for therapy of solid tumors. Ann Surg 175:409-416.
46. Folkman J, Kalluri R. 2004. Cancer without disease. Do inhibitors of blood-vessel growth found naturally in our bodies defend most of us against progression of cancer to a lethal stage? Nature 427:787.
47. Frieden IJ, Haggstrom AN, Drolet BA, Mancini AJ, Friedlander SF, Boon L, Chamlin SL, Baselga E, Garzon MC, Nopper AJ, Siegel DH, Mathes EW, Goddard DS, Bischoff J, North PE, Esterly NB. 2005. Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Pediatr Dermatol 22:383-406.
48. Furukawa T, Igata A, Toyokura Y, Ikeda S. 1970. Sturge-Weber and Klippel-Trenaunay syndrome with nevus of Ota and Ito. Arch Dermatol 102:640-645.
49. Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, Markel D, Vikkula M, Mulliken JB, Warman ML, Pericak-Vance MA, Marchuk DA. 1995. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 32:197-199.
50. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. 2003. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300:1155-1159.
51. Gariano RF, Gardner TW. 2005. Retinal angiogenesis in development and disease. Nature 438:960-966.
52. Gerety SS, Wang HU, Chen Z-F, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Molec Cell 4:403-414.
53. Gorlin RJ, Kantaputra P, Aughton DJ, Mulliken JB. 1994. Marked female predilection in some syndromes associated with facial hemangiomas. Am J Med Genet 52:130-135.
54. Gottron HA, Schnyder UW. 1966. Vererbung von Hautkrankheiten. In: Hanbuch dr Haut- und Geschlechtskrankheiten, Vol. 7. p. 715. Berlin: Springer-Verlag.
55. Gourie-Devi M, Prakash B. 1978. Vertebral and epidural hemangioma with paraplegia in Klippel-Trénaunay syndrome. J Neurosurg 48:814-817.
56. Greenberg DA, Jin K. 2005. From angiogenesis to neuropathology. Nature 438:954-959.
57. Han Z, Ni J, Smits P, Underhill CB, Xie B, Chen Y, Liu N, Tylzanowski P, Parmelee D, Feng P. 2001. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J 15:988-994.
58. Hanahan D. 1997. Signaling vascular morphogenesis and maintenance. Science 277:48-50.
59. Happle R. 1993. Klippel-Trenaunay syndrome: Is it a paradominant trait? Br J Dermatol 128:465.
60. Hennekam RCM, Geerdink RA, Hammel BCJ, Hennekam FAM, Kraus P, Rammeloo JA, Tillemans AA. 1989. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet 34:593-600.
61. Heuser M. 1971. De l'entité nosologique des angiomatses neurocutanées (Sturge-Weber et Klippel-Trénaunay). Rev Neurol (Paris) 124:213-228.
62. Imayama S, Murakamai Y, Hashimoto H, Hori Y. 1992. Spindle cell hemangioendothelioma exhibits the ultrastructural features of reactive vascular proliferation rather than of angiosarcoma. Am J Clin Pathol 97:279-287.
63. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67:295-301.
64. Irrthum A, Devriendt K, Chitayat D, Matthijs G, Glade C, Steijlen PM, Fryns J-P, Van Steensel MAM, Vikkula M. 2003. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis- lymphedema-telangiectasia. Am J Hum Genet 72:1470-1478.
65. Jaffe HL. 1964. Tumors and Tumorous Conditions of Bones and Joints. Philadelphia: Lea & Febiger.
66. Jain RK. 2005. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58-62.
67. Karkkainen MJ, Petrova TV. 2000. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19:5598-5605.
68. Karkkainen M, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25:153-159.
69. Kassarjian A, Dubois J, Burrows PE. 2002. Angiographic classification of hepatic hemangiomas in infants. Radiology 222:693-698.
70. Kassarjian A, Zurakowski D, Dubois J, Burrows PE. 2004. Infantile hepatic hemangiomas: Clinical and imaging findings and their correlation with therapy. Am J Roentgenol 182:785-795.
71. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H. 1999. A requirement for neuropilin-1 in embryonic vessel formation. Develop 126:4895-4902.
72. Kerbel RS. 2000. Tumor angiogenesis: Past, present and the near future. Carcinogenesis 21:505-515.
73. Kitsukawa T, Shimizu M, Sanbo M, Hirata T, Taniguchi M, Bekku Y, Yagi T, Fujisawa H. 1997. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron 19:995-1005.
74. Klippel M, Trenaunay P. 1900. Du naevus variqueux osté ohypertrophique. Arch Gén Méd Paris 3:611-672.
75. Koch G. 1956. Zur Klinik; Symptomatologie, Pathogenese und Erbpathologie des Klippel-Trenaunay-Weberschen syndroms. Acta Genet Med Gemellol 5:326-370.
76. Kondo K, Tanaka K, Fujii T, Akita S. 1997. Klippel-Trenaunay-Weber syndrome associated with intra-abdominal lymphangioma requiring multiple surgical interventions. Ann Plast Surg 39:435-437.
77. Korpelainen EJ, Kärkkäinen M, Gunji Y, Vikkula M, Alitalo K. 1999. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant TIE-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18:1-8.
78. Lai L, Bohnsack BL, Niederreither K, Hirschi KK. 2003. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Develop 130:6465-6474.
79. Lammert E, Cleaver O, Melton D. 2001. Induction of pancreatic differentiation by signals from blood vessels. Science 294:564-567.
80. Lian C, Alhomme P. 1945. Les varices congénitale par dysembryoplasie (syndrome de Klippel-Trenaunay). Arch Mal Coeur 38:176.
81. Lindenauer SM. 1965. The Klippel-Trenaunay-Weber syndrome: Varicosity, hypertrophy, and hemangioma with no arteriovenous fistula. Ann Surg 162:303-314.
82. Lu X, le Noble F, Yuan L, Jiang Q, de Lafarge B, Suglyama D, Bréant C, Claes F, De Smet F, Thomas J-L, Autiero M, Carmeliet P, Tessier-Lavigne M, Eichmann A. 2004. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 432:179-186.
83. Maari C, Frieden IJ. 2004. Klippel-Trénaunay syndrome: The importance of "geographic stains" in identifying lymphatic disease and risk of complications. J Am Acad Dermatol 51:391-398.
84. Marshall E. 2002. Setbacks for Endostatin. Science 295:2198-2199.
85. Marx J. 2003. A boost for tumor starvation. Science 301:452-454.
86. Matsumoto K, Yoshitomi H, Rossant J, Zaret KS. 2001. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 294:559-563.
87. Metry DW, Dowd CF, Barkovich J, Frieden IJ. 2001. The many faces of PHACE syndrome. J Pediatr 139:117-123.
88. Moore CA, Toriello HV, Abuelo DN, Bull MJ, Curry CJR, Hall BD, Higgins JV, Stevens CA, Twersky S, Weksberg R, Dobyns WB. 1997. Macrocephaly-cutis marmorata telangiectatica congenita: a distinct disorder with developmental delay and connective tissue abnormalities. Am J Med Genet 70:67-73.
89. Mulliken JB. 1993. Cutaneous vascular anomalies. Semin Vasc Surg 6:204-218.
90. th ed. Philadelphia, Lippincott-Raven, pp. 191-203.
91. Mulliken JB. 2006 (in press). Diagnosis and natural history of hemangiomas (Chapter 5). In: Mulliken JB, Fishman SJ, Burrows PE, editors. Vascular Anomalies, Hemangiomas, and Malformations. New York: Oxford University Press.
92. Mulliken JB, Enjolras O. 2004. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 50:875-882.
93. Mulliken JB, Glowacki J. 1982. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 69:412-420.
94. Mulliken JB, Young AE. 1988. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia: Saunders.
95. Mäkinen T, Veikkola T, Mustjoki S, Karpanen T, Catimal B, Nice EC, Wise L, Mercer A, Kowalski H, Kerjaschki D, Stacker SA, Achen MG, Alitalo K. 2001. Isolated lymphatic endothelial cells transduce growth, survival and migratory signal via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762-4773.
96. Musumeci ML, Nasca MR, De Pasquale R, Schwartz RA, Micali G. 2006. Cutaneous manifestations and massive genital involvement in Hennekam syndrome. Pediatric Derm 23:239-242.
97. Nakamura T, Mochizuki Y, Kanetake H, Kanda S. 2001. Signals via FGF receptor 2 regulate migration of endothelial cells. Biochem Biophys Res Commun 289:801-806.
98. Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y. 2002. The neuropilins: Multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12:13-19.
99. North PE, Waner M, Mizeracki A, Mihm MC. 2000. GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11-22.
100. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, Suen JY, Mihm MC. 2001. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137:559-570.
101. Norwood OT, Everett MD. 1964. Cardiac failure due to endocrine dependent hemangiomas. Arch Dermatol 89:759-760.
102. O'Connor PS, Smith JL. 1978. Optic nerve variant in the Klippel-Trénaunay-Weber syndrome. Ann Ophthalmol 10:131-137.
103. OMIM. 2005. Online Mendelian Inheritance in Man.
104. Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. 1995. Cervicofacial lymphatic malformation: Clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 95:951-960.
105. Park KW, Morrison CM, Sorensen LK, Jones CA, Rao Y, Chien C-B, Wu JY, Urness LD, Li DY. 2003. Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol 261:251-267.
106. Parker LH, Schmidt M, Jin S-W, Gray AM, Bels D, Pham T, Frantz G, Palmieri S, Hillan K, Stainler DYR, de Sauvage FJ, Ye W. 2004. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428:754-758.
107. Parkes Weber F. 1907. Angioma formation in connection with hypertrophy of limbs and hemihypertrophy. Br J Dermatol 19:231.
108. Parkes Weber F. 1908. Haemangiectatic hypertrophies of the foot and lower extremity. Med Press (Lond) 136:261.
109. Parkes Weber F. 1918. Haemangiectatic hypertrophy of the limbs - congenital phlebarteriectasis and so-called congenital varicose veins. Br J Child Dis 15:13.
110. Perkins P, Weiss SW. 1996. Spindle cell hemangioendothelioma: An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol 20:1196-1204.
111. Plate KH. 2001. From angiogenesis to lymphangiogenesis. Nat Med 7:151-152.
112. Poole TJ, Finkelstein EB, Cox CM. 2001. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dynamics 220:1-17.
113. Prasad V, Fishman SJ, Mulliken JB, Fox VL, Liang MG, Klement G, Kieran MW, Burrows PE, Waltz DA, Powell J, Dubois J, Levy ML, Perez-Atayde AR, Kozakewich HPW. 2005. Cutaneovisceral angiomatosis with thrombocytopenia. Pediatr Dev Pathol 8:407-419.
114. Rademacher R. 1961. Über einen Fall einer Kombination von Sturge-Weber und Klippel-Trénaunay-Syndrom mit konstitutioneller Neurodermitis. Dermatol Wochenschr 143:381-386.
115. Robertson DJ. 1956. Congenital arteriovenous fistulae of the extremities. Ann Roy Coll Surg Engl 18:73.
116. Robertson SP, Gattas M, Rogers M, Adès LC. 2000. Macrocephalycutis marmorata telangiectatica: Report of five patients and a review of the literature. Clin Dysmorphol 9:1-9.
117. Rupnick MA, Panigrahy D, Zhang C-Y, Dallabrida SM, Lowell BB, Langer R, Folkman MJ. 2002. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99:10730-10735.
118. Saaristo A, Karpanen T, Alitalo K. 2000. Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis. Oncogene 19:6122-6129.
119. Samuel M, Spitz L. 1995. Klippel-Trenaunay syndrome: Clinical features, complications and management in children. Br J Surg 82:757-761.
120. Sarkar M, Mulliken JB, Kozakewich HPW, Robertson RL, Burrows PE. 1997. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 100:1377-1386.
121. Schönenberg H, Redemann M. 1972. Klippel-Trénaunay-Weber Syndrom. Klin Pädiatr 184:449-460.
122. Servelle M. 1985. Klippel and Trenaunay's syndrome. 768 operated cases. Ann Surg 201:365-373.
123. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardeña G, Papapetropoulos A, Sessa WC, Mage LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR. 2000. Biological action of leptin as an angiogenic factor. Science 281:1683-1686.
124. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. 2001. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198.
125. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735-745.
126. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S-I, Kubo H, Achen MG. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191.
127. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB. 1994. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 93:2357-2364.
128. Takakura N, Watanabe T, Suenobu S, Yamada Y, Noda T, Ito Y, Satake M, Suda T. 2000. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102:199-209.
129. Teller H, Lindner B. 1952. Über Mischformen der phakomatahosen Syndrome von Sturge-Weber und Klippel-Trénaunay. Z Haut Geschlechtskr 13:113-120.
130. Tennant LB, Mulliken JB, Perez-Atayde AR. 2006. Verrucous hemangioma revisited. Pediatric Derm 23:208-215.
131. Tian X-L, Kadaha R, You S-A, Liu M, Timur AA, Yang L, Chen Q, Szafranski P, Rao S, Wu L, Housman DE, DiCerieto PE, Driscoll DJ, Barrow J, Wang Q. 2004. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427:640-645.
132. Torres-Vásquez J, Gitler AD, Fraser SD, Berk JD, Pham VN, Fishman MC, Childs S, Epstein JA, Weinstein BM. 2004. Semaphorin-Plexin signaling guides patterning of the developing vasculature. Dev Cell 7:117-123.
133. Van Balkom IDC, Alders M, Allanson J, Bellini C, Frank U, DeJong G, Kolbe I, Lacombe D, Rockson S, Rowe P, Wijburg F, Hennekam RCM. 2002. Lymphedema-lymphangiectasiamental retardation (Hennekam) syndrome: A review. Am J Med Genet 112:412-421.
134. Van Der Zwaag B, Hellemons AJCGM, Leenders WPJ, Burbach JPH, Brunner HG, Padberg GW, Van Bokhoven H. 2002. PLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesis. Dev Dyn 225:336-343.
135. Vargel I, Cil BE, Er N, Ruacan S, Akarsu AN, Erk Y. 2002. Hereditary intraosseous vascular malformation of the craniofacial region: an apparently novel disorder. Am J Med Genet 109:22-35.
136. Vikkula M, Boon LM, Carraway KL III, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR. 1996. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190.
137. Vikkula M, Karkkainen MJ, Alitalo K. 2004. Angiopoietins, TIEs, ephrins, vascular endothelial growth factors, and vascular endothelial growth factor receptors. In: Epstein CJ, Erickson RP, Wynshaw-Boris A, editors. From Inborn Errors of Development. New York: Oxford University Press, Chapter 101, pp. 987-996.
138. Vokes SA, Krieg PA. 2002. Endoderm is required for vascular endothelial tube formation, but not for angioblast specification. Development 129:775-785.
139. Walter JW, North PE, Waner M, Mizeracki A, Biel F, Walker JWT, Reinisch JF, Marchuk DA. 2002. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chrom Cancer 33:295-303.
140. Wang HU, Chen Z-F, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753.
141. Weinstein BM. 2005. Vessels and nerves: Marching to the same tune. Cell 120:299-302.
142. Weiss SW, Enzinger FM. 1986. Spindle cell hemangioendothelioma - a low grade angiosarcoma resembling a cavernous hemangioma and Kaposi's sarcoma. Am J Surg Pathol 10:521-530.
143. th Annual David W. Smith Workshop on Malformations and Morphogenesis, August 5-9, Wake Forest University, Winston-Salem, North Carolina.
144. Whelan AJ, Watson MS, Porter FD, Steiner RD. 1995. Klippel-Trenaunay- Weber syndrome associated with a 5:11 balanced translocation. Am J Med Genet 59:492-494.
145. Wilson-Jones E, Orkin M. 1989. Tuftedangioma (angioblastoma). J Am Acad Dermatol 20:214-225.
146. Wilting J, Aref Y, Huang R, Tomarev SI, Schweigerer L, Christ B, Valasek P, Papoutsi M. 2006. Dual origin of avian lymphatics. Dev Biol 292:165-173.
147. Yancopoulos GD, Kiagsbrun M, Folkman J. 1998. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border. Cell 93:661-664.
148. Young AE. 1978. Mixed vascular deformities. M Chir Thesis, University of Cambridge, Cambridge, England.
149. Young AE. 1988. Hemangiomas and malformations. In: Mulliken JB, Young AE, editors. Vascular Birthmarks. Philadelphia: W.B. Saunders.
150. Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J. 2001. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 159:2271-2280.
151. Zins JE, Türegün M, Hosn W, Bauer TW. 2006. Reconstruction of intraosseoiis hemangiomas of the inidface using split calvarial bone grafts. Plast Reconstr Surg 117:948-953.
152. Zuckerberg LB, Nickoloff BJ, Weiss SW. 1993. Kaposiform hemangioendothelioma of infancy and childhood: An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321-328.